Page last updated: 2024-08-24

aripiprazole and Emesis

aripiprazole has been researched along with Emesis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Açıkel, B; Hergüner, S; Yar, A1
Cantrell, FL; Clark, RF; Shah, N; Young, MC1
Assuncao-Talbott, S; Blumer, J; Boulton, DW; Findling, RL; Iwamoto, T; Kauffman, R; Kollia, G; Kornhauser, DM; Mallikaarjun, S; McQuade, RD; Sahasrabudhe, V; Salazar, DE; Sallee, FR; Vachharajani, NN1
Ebrecht, M; Kungel, M; Messer, T; Modell, S; Schmauss, M; Spevakne-Goeroecs, T; Werner, C1
Auby, P; Manos, G; Marcus, RN; McQuade, RD; Oren, DA; Stock, E; Zimbroff, DL1
Inoue, T; Kurokawa, K; Nakamura, A; Narita, M; Shiokawa, M; Suzuki, T1

Trials

2 trial(s) available for aripiprazole and Emesis

ArticleYear
Clinical use of aripiprazole in patients with schizophrenia: a real-life setting results from the German Postmarketing Surveillance Study.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2010, Volume: 11, Issue:2 Pt 2

    Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Germany; Humans; Male; Nausea; Piperazines; Product Surveillance, Postmarketing; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Sleep Initiation and Maintenance Disorders; Vomiting

2010
Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2

    Topics: Acute Disease; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Injections, Intramuscular; Lorazepam; Male; Nausea; Patient Dropouts; Piperazines; Psychomotor Agitation; Quinolones; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Vomiting

2007

Other Studies

4 other study(ies) available for aripiprazole and Emesis

ArticleYear
Functional Vomiting Treated Successfully with Aripiprazole in a Child with Autism Spectrum Disorder.
    Journal of child and adolescent psychopharmacology, 2016, Volume: 26, Issue:2

    Topics: Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Child; Humans; Male; Treatment Outcome; Vomiting

2016
Risk assessment of isolated aripiprazole exposures and toxicities: a retrospective study.
    Clinical toxicology (Philadelphia, Pa.), 2009, Volume: 47, Issue:6

    Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Child; Child, Preschool; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Dystonia; Female; Humans; Infant; Male; Middle Aged; Nausea; Piperazines; Poison Control Centers; Poisoning; Quinolones; Retrospective Studies; Risk Assessment; Tachycardia, Sinus; Vomiting; Young Adult

2009
An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder.
    Journal of child and adolescent psychopharmacology, 2009, Volume: 19, Issue:4

    Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Child; Conduct Disorder; Female; Follow-Up Studies; Humans; Male; Piperazines; Prospective Studies; Quinolones; Tremor; Vomiting

2009
Usefulness of the dopamine system-stabilizer aripiprazole for reducing morphine-induced emesis.
    European journal of pharmacology, 2007, Sep-10, Volume: 570, Issue:1-3

    Topics: Analgesics, Opioid; Animals; Antipsychotic Agents; Aripiprazole; Ferrets; Male; Morphine; Piperazines; Quinolones; Receptors, Dopamine D2; Vomiting

2007